SLDB ▲ +0.4% - Solid Biosciences Inc.
$SLDB int Outperform @ RBC pt 18
Solid Biosciences rose 0.4% following an Outperform rating from RBC Capital Markets with a price target of $18, suggesting the analyst sees upside from current levels.
16-SEP-2026 06:21 AM ET
Share this post
More filings for $SLDB
SLDB ▼ -3.2% - Solid Biosciences Inc.Oct 1, 2026SLDB ▼ -1.0% - Solid Biosciences Inc.Sep 2, 2026SLDB - Solid Biosciences Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026SLDB - Solid Biosciences Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026SLDB - Solid Biosciences Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 6, 2026$SLDB SEC Filing Update (30-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 30, 2026
View full $SLDB filing history →💬 Comments
Loading comments…
Leave a comment